Search

In Stock

Buy Ondexxya (andexanet alfa) Online

DISEASE INDICATIONS: Thromboembolism

MANUFACTURER: Alexion Pharmaceuticals

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.

$16,421.35

Clear
Compare

Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required. Here is a detailed description of Ondexxya (Andexanet Alfa):

  1. Mechanism of Action: Andexanet alfa is a recombinant modified human factor Xa protein. It works by binding to and sequestering specific anticoagulant drugs known as direct oral factor Xa inhibitors, such as apixaban and rivaroxaban. These anticoagulants work by inhibiting factor Xa, an enzyme involved in the blood clotting process. By binding to these drugs, Andexanet Alfa effectively neutralizes their anticoagulant effects, allowing normal blood clotting to resume.
  2. Indications: Ondexxya is indicated for the reversal of the anticoagulant effects of apixaban and rivaroxaban in adult patients with life-threatening or uncontrolled bleeding. It is also approved for patients requiring urgent surgery or invasive procedures where rapid reversal of anticoagulation is essential.
  3. Administration: Andexanet alfa is typically administered as an intravenous (IV) infusion in a healthcare setting. The dose and duration of the infusion depend on various factors, including the specific anticoagulant being reversed, the dose of the anticoagulant, and the patient’s condition.
  4. Effectiveness: Clinical studies have demonstrated the effectiveness of Ondexxya in rapidly reversing the anticoagulant effects of apixaban and rivaroxaban. It allows for the restoration of normal blood clotting and can be crucial in managing severe bleeding or preparing patients for urgent surgery or procedures.
  5. Safety Profile: Like all medications, Andexanet Alfa may have potential side effects, including infusion-related reactions, headache, and altered sense of taste. However, it is generally well-tolerated, and the benefits of rapid anticoagulant reversal typically outweigh potential risks.
  6. Monitoring: Patients who receive Ondexxya are closely monitored by healthcare providers for signs of bleeding or thrombotic events. This ensures that the reversal of anticoagulation is effective without causing new complications.
  7. Contraindications: Andexanet alfa is generally not recommended for individuals with known hypersensitivity to the drug or those with a history of serious thromboembolic events (such as stroke or heart attack) within the past two weeks.
  8. Research and Development: Ondexxya represents a critical advancement in the field of anticoagulant therapy, as it provides a targeted and effective reversal option for patients taking direct oral factor Xa inhibitors. Ongoing research may explore its use in other clinical scenarios and its long-term safety and efficacy.

It is essential for healthcare providers to be knowledgeable about Ondexxya (Andexanet Alfa) and its proper administration, especially in emergency situations involving patients on direct oral factor Xa inhibitors. Rapid and effective reversal can be life-saving in cases of severe bleeding or the need for urgent medical procedures.

Package

4 vials of 100 mg, 4 vials of 200 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Ultomiris (ravulizumab) Online

(0 Reviews)
MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Buy Cablivi (caplacizumab) Online

$4,125.96
(0 Reviews)
DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP) MANUFACTURER: Ablynx NV USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Cablivi, with its active ingredient caplacizumab, is a prescription medication used in the treatment of a rare and serious medical condition known as acquired thrombotic thrombocytopenic purpura (aTTP).

Buy Inrebic (fedratinib) Online

$5,242.36
(0 Reviews)
DISEASE INDICATIONS: Myelofibrosis MANUFACTURER: Impact Biomedicines, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.

Buy Oxbryta (voxelotor) Online

$33,074.12
(0 Reviews)
ISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Global Blood Therapeutics, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).

Buy Evrenzo (Roxadustat) Online

From $171.42
(0 Reviews)
DISEASE INDICATIONS: Anemia MANUFACTURER: Astellas Pharma Inc. FibroGen USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Back to Top
Product has been added to your cart